The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant treatment strategy and results in small breast cancer tumors (pT1) with HER2 overexpression.
A. Hinke
No relevant relationships to disclose
P. Dall
No relevant relationships to disclose
G. Lenzen
No relevant relationships to disclose
C. Schumacher
No relevant relationships to disclose
D. Rezek
No relevant relationships to disclose
N. Gazawi
No relevant relationships to disclose
A. Ammon
No relevant relationships to disclose
F. G. Foerster
No relevant relationships to disclose
F. Beldermann
No relevant relationships to disclose
U. Cirrincione
No relevant relationships to disclose
J. Wilke
No relevant relationships to disclose